Is Mounjaro Long-Acting? Weekly Dosing Explained Written by Bolt Pharmacy Published 5/11/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a long-acting medication administered once weekly for type 2 diabetes and weight management. Unlike short-acting treatments requiring daily or multiple daily doses, Mounjaro’s extended pharmacokinetic profile provides sustained therapeutic effects over seven days. This dual GIP and […]
Tag Archives: Mounjaro Medical Guide
Mounjaro in the Arm: Safe Injection Sites and Technique Written by Bolt Pharmacy Published 5/11/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, administered via once-weekly subcutaneous injection. Many patients wonder whether Mounjaro can be injected in the arm, particularly if […]
Mounjaro and Colon Cancer: Evidence, Risk and Safety Guidance Written by Bolt Pharmacy Published 30/10/2025 Last Updated 21/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Recent discussions have raised questions about Mounjaro and colon cancer risk, prompting concern amongst patients and […]
Does Mounjaro Cause Fever? UK Clinical Guidance Written by Bolt Pharmacy Published 31/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus. Patients and clinicians often ask: does Mounjaro cause fever? Fever is not listed as a common side effect in the […]
Mounjaro: What Supplements to Take During Treatment Written by Bolt Pharmacy Published 14/10/2025 Last Updated 2/6/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes management, with significant effects on appetite and gastric emptying. Many patients wonder what supplements to take with Mounjaro to support nutritional […]